Krishnasamy Meinir, Kwok-Wei So Winnie, Yates Patsy, de Calvo Luz Esperanza Ayala, Annab Rachid, Wisniewski Tami, Aranda Sanchia
Author Affiliations: Peter MacCallum Cancer Centre and Faculty of Medicine, Dentistry, and Health Sciences, The University of Melbourne, Victoria, Australia (Drs Krishnasamy and Aranda and Mr Annab); Nethersole School of Nursing, Chinese University of Hong Kong, China (Dr Kwok-wei So); School of Nursing and Midwifery, Queensland University of Technology, Queensland, Australia (Dr Yates); School of Nursing, Pontificia Universidad Javeriana, Bogota, Colombia (Ms de Calvo); Merck & Co Inc, Whitehouse Station, New Jersey (Ms Wisniewski); Cancer Institute New South Wales, Sydney, Australia (Professor Aranda).
Cancer Nurs. 2014 Jul-Aug;37(4):E27-35. doi: 10.1097/NCC.0b013e3182a3534a.
Nurses play a substantial role in the prevention and management of chemotherapy-induced nausea and vomiting (CINV).
This study set out to describe nurses' roles in the prevention and management of CINV and to identify any gaps that exist across countries.
A self-reported survey was completed by 458 registered nurses who administered chemotherapy to cancer patients in Australia, China, Hong Kong, and 9 Latin American countries.
More than one-third of participants regarded their own knowledge of CINV as fair to poor. Most participants (>65%) agreed that chemotherapy-induced nausea and chemotherapy-induced vomiting should be considered separately (79%), but only 35% were confident in their ability to manage chemotherapy-induced nausea (53%) or chemotherapy-induced vomiting (59%). Only one-fifth reported frequent use of a standardized CINV assessment tool and only a quarter used international clinical guidelines to manage CINV.
Participants perceived their own knowledge of CINV management to be insufficient. They recognized the need to develop and use a standardized CINV assessment tool and the importance of adopting international guidelines to inform the management of CINV.
Findings indicate that international guidelines should be made available to nurses in clinically relevant and easily accessible formats, that a review of chemotherapy assessment tools should be undertaken to identify reliable and valid measures amenable to use in a clinical settings, and that a CINV risk screening tool should be developed as a prompt for nurses to enable timely identification of and intervention for patients at high risk of CINV.
护士在化疗所致恶心和呕吐（CINV）的预防和管理中发挥着重要作用。
本研究旨在描述护士在CINV预防和管理中的作用，并确定各国存在的差距。
458名在澳大利亚、中国、中国香港以及9个拉丁美洲国家为癌症患者实施化疗的注册护士完成了一项自填式调查。
超过三分之一的参与者认为自己对CINV的了解一般或较差。大多数参与者（>65%）同意化疗所致恶心和化疗所致呕吐应分开考虑（79%），但只有35%的人对自己管理化疗所致恶心（53%）或化疗所致呕吐（59%）的能力有信心。只有五分之一的人报告经常使用标准化的CINV评估工具，只有四分之一的人使用国际临床指南来管理CINV。
参与者认为自己对CINV管理的知识不足。他们认识到需要开发和使用标准化的CINV评估工具，以及采用国际指南指导CINV管理的重要性。
研究结果表明，应向护士提供以临床相关且易于获取的形式呈现的国际指南，应对化疗评估工具进行审查以确定适用于临床环境的可靠且有效的措施，并且应开发CINV风险筛查工具，以促使护士及时识别CINV高危患者并进行干预。
